UF Health Researcher Explains Herd Immunity and How It Could End COVID-19 Pandemic
Cindy A. Prins, Ph.D., M.P.H., a University of Florida Health infectious disease epidemiologist who is an associate professor in the UF College of Public Health and Health Professions and the UF College of Medicine, looks at herd immunity and explains how it might be part of the answer.
UF Health Launches NIH-Sponsored Trial to ‘POuND OUT’ Painful Kidney Stones
Kidney stones can be excruciatingly painful and dangerous, but relief may be on the way. A new University of Florida Health clinical trial will test two existing drugs that may slow the growth of these stones or prevent them from forming.
Parent Project Muscular Dystrophy Awards $348,891 Grant to University of Florida Wellstone Center
Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy, awarded the University of Florida Wellstone Muscular Dystrophy Cooperative Center a grant for $348,891.
World-Renowned UF Health Biochemistry Researcher Mavis Agbandje-McKenna, Ph.D., Dies
University of Florida Health biochemistry professor Mavis Agbandje-McKenna, Ph.D., whose world-renowned work on the detailed structure of viruses led to advances in gene therapy treatments for different diseases, died Wednesday (March 3) at her home near Gainesville of the neurodegenerative disease amyotrophic lateral sclerosis.
UF Health Sepsis Study Uses AI Technology, Urinary Cellular Gene Expression for Early Detection
A groundbreaking study conducted by a multidisciplinary team of researchers at the University of Florida Sepsis and Critical Illness Research Center explores how urine analysis during early onset of sepsis may help determine the likelihood of chronic kidney problems in the long term.
Jennifer Bizon, Ph.D., Named Chair of UF Department of Neuroscience
University of Florida neuroscientist Jennifer Bizon, Ph.D., an expert in brain aging, has been named chair of the UF College of Medicine’s department of neuroscience.
UF Researchers Granted $2 Million for Liver Disease Research
UF Health researchers were granted more than $2 million to screen for fatty liver disease, in what could be the largest study of its kind. The National Institute of Health grant will fund the screening of more than 1,000 patients over the next two-and-a-half years.
UF Health Researcher Helps Show Hormone Can Reverse Inflammation From Fatty Liver Disease
Pushed by the obesity epidemic, a rising number of Americans are being diagnosed with nonalcoholic fatty liver disease, a condition that can lead to liver inflammation and cirrhosis. It is now the leading cause of liver transplantation in the United States.
Lacerta Therapeutics Strengthens Its Position in the AAV Gene Therapy Space With New Leadership
UF startup and UF Innovate | Sid Martin Biotech alum Lacerta Therapeutics, a clinical-stage gene therapy company, announced new leadership. Dr. Edgar... Read More
Therapeutics Company Announces Exclusive Licensing Agreements for Hearing Loss Gene Therapy Technology Developed by UF Researcher
Decibel Therapeutics, a clinical-stage biotechnology company developing novel restorative gene therapeutics to treat hearing loss and balance disorders, has announced exclusive license... Read More
